BR112023025042A2 - Pirrol[2,3-d]pirimidinas substituídas, preparação das mesmas e aplicação terapêutica das mesmas - Google Patents
Pirrol[2,3-d]pirimidinas substituídas, preparação das mesmas e aplicação terapêutica das mesmasInfo
- Publication number
- BR112023025042A2 BR112023025042A2 BR112023025042A BR112023025042A BR112023025042A2 BR 112023025042 A2 BR112023025042 A2 BR 112023025042A2 BR 112023025042 A BR112023025042 A BR 112023025042A BR 112023025042 A BR112023025042 A BR 112023025042A BR 112023025042 A2 BR112023025042 A2 BR 112023025042A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrimidines
- preparation
- compounds
- therapeutic application
- substituted pyrrol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/188—Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21315095.6A EP4105218A1 (en) | 2021-06-15 | 2021-06-15 | Substituted pyrrolo[2,3-d] pyrimidines, their preparation and their therapeutic application |
| EP22315117 | 2022-06-02 | ||
| PCT/EP2022/066231 WO2022263472A1 (en) | 2021-06-15 | 2022-06-14 | Substituted pyrrolo[2,3-d]pyrimidines, their preparation and their therapeutic application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023025042A2 true BR112023025042A2 (pt) | 2024-02-27 |
Family
ID=82214141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023025042A BR112023025042A2 (pt) | 2021-06-15 | 2022-06-14 | Pirrol[2,3-d]pirimidinas substituídas, preparação das mesmas e aplicação terapêutica das mesmas |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240383901A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355748B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7886355B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240021910A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022294022A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023025042A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223786A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024000083A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309195A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023015016A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022263472A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL330303A (en) * | 2023-12-27 | 2026-08-01 | Sanofi | Modified pyrrolo[2,3-d]pyrimidins, their preparation and therapeutic applications |
| KR20250163526A (ko) | 2024-05-14 | 2025-11-21 | 김성우 | 음전하 증폭장치가 장착된 어싱용 발판 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI398252B (zh) * | 2006-05-26 | 2013-06-11 | 諾華公司 | 吡咯并嘧啶化合物及其用途 |
| FR2988722B1 (fr) | 2012-04-03 | 2014-05-09 | Sanofi Sa | Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques |
| CN106146515B (zh) | 2015-04-17 | 2020-09-04 | 常州隆赛医药科技有限公司 | 新型激酶抑制剂的制备及应用 |
| US11214565B2 (en) | 2015-11-20 | 2022-01-04 | Denali Therapeutics Inc. | Compound, compositions, and methods |
| CN108934162A (zh) | 2015-12-16 | 2018-12-04 | 南方研究所 | 吡咯并嘧啶化合物、作为激酶lrrk2抑制剂的用途及其制备方法 |
| EP3587422A4 (en) | 2017-02-22 | 2020-05-06 | Daegu-Gyeongbuk Medical Innovation Foundation | PYRROLOPYRIMIDINE DERIVATIVE COMPOUND, PRODUCTION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION WITH THIS COMPOUND AS AN ACTIVE SUBSTANCE FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE |
| EP3873471B1 (en) | 2018-10-31 | 2025-12-31 | Merck Sharp & Dohme LLC | N-HETEROARYL INDAZOLE DERIVATIVES AS LRRK2 INHIBITORS: PHARMACEUTICAL COMPOSITIONS AND THEIR USES |
| EP3915985A4 (en) | 2019-01-18 | 2022-09-28 | Voronoi Co., Ltd. | PYRROLOPYRIDE DERIVATIVE AND USE THEREOF FOR THE PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISEASES |
-
2022
- 2022-06-14 MX MX2023015016A patent/MX2023015016A/es unknown
- 2022-06-14 IL IL309195A patent/IL309195A/en unknown
- 2022-06-14 WO PCT/EP2022/066231 patent/WO2022263472A1/en not_active Ceased
- 2022-06-14 US US18/569,790 patent/US20240383901A1/en active Pending
- 2022-06-14 BR BR112023025042A patent/BR112023025042A2/pt unknown
- 2022-06-14 EP EP22733628.6A patent/EP4355748B1/en active Active
- 2022-06-14 JP JP2023577130A patent/JP7886355B2/ja active Active
- 2022-06-14 KR KR1020247001337A patent/KR20240021910A/ko active Pending
- 2022-06-14 CA CA3223786A patent/CA3223786A1/en active Pending
- 2022-06-14 AU AU2022294022A patent/AU2022294022A1/en active Pending
-
2024
- 2024-01-05 CO CONC2024/0000083A patent/CO2024000083A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024525150A (ja) | 2024-07-10 |
| IL309195A (en) | 2024-02-01 |
| JP7886355B2 (ja) | 2026-07-07 |
| WO2022263472A1 (en) | 2022-12-22 |
| KR20240021910A (ko) | 2024-02-19 |
| CO2024000083A2 (es) | 2024-04-08 |
| US20240383901A1 (en) | 2024-11-21 |
| MX2023015016A (es) | 2024-05-31 |
| EP4355748A1 (en) | 2024-04-24 |
| AU2022294022A1 (en) | 2024-02-01 |
| EP4355748C0 (en) | 2026-05-13 |
| CA3223786A1 (en) | 2022-12-22 |
| EP4355748B1 (en) | 2026-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA59373B1 (fr) | [1,3]diazino[5,4-d]pyrimidines en tant qu'inhibiteurs de her2 | |
| BRPI0411863A (pt) | derivados de pirazolil-indol como inibidores de cinase, processo para seu preparo e composições farmacêuticas compreendendo os mesmos | |
| BRPI0411868B8 (pt) | derivados de pirrol[3,4-c]pirazol ativos como inibidores de cinase | |
| BR122019010200B8 (pt) | compostos de pirazol-quinazolina, seus sais, produtos ou kits e composições farmacêuticas | |
| BR112012030820A8 (pt) | Derivados de aminopirimidina como moduladores de lrrk2, seu uso e composição que os compreende | |
| SI1427708T1 (sl) | Derivati amino-ftalazinona kot zaviralci kinaze, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo | |
| BR112017016487A2 (pt) | 7-benzil-4- (2-metilbenzil) -2,4,6,7,8,9-hexahidroimidazo [1,2-a] pirrido [3,4-e] pirimidin-5 (1h) -ona, análogos desta, e sais do mesmo e métodos para sua utilização na terapia | |
| BRPI0414111A (pt) | inibidores heterocìclicos de mek e métodos de uso dos mesmos | |
| BRPI0614168A2 (pt) | Composto ou um sal, hidrato, solvato, isoforma, tautômero, isômero óptico farmaceuticamente aceitável ou uma combinação dos mesmos, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psquiátricos, uso de um composto, e, processo para a preparação de um composto | |
| BR0307819A (pt) | Derivados de pirazol tricìclicos, processo para preparação dos mesmos como agentes antitumorais | |
| EA201000552A1 (ru) | Производные пирроло[2,3-d]пиримидина в качестве ингибиторов протеинкиназы в | |
| BR0308196A (pt) | Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com a glicogênio sintase cinase-3, e de doenças, e, processo para a preparação de um composto | |
| BR112015028501B8 (pt) | Compostos derivados de bipirazol, seus sais, composição compreendendo o composto ou o sal, método de inibição in vitro de uma atividade de jak1, e processo de preparação de sal de ácido fosfórico | |
| BRPI0807346B8 (pt) | derivados de 3-amino-pirrolo[3,4-c]pirazol-5(1h,4h,6h)carbaldeído como inibidores de pkc, seu uso e composição farmacêutica que os compreende | |
| NO20084496L (no) | Pyridyl- og pyrimidinylsubstituerte pyrrol-, tiofen- og furanderivater som kinaseinhibitorer | |
| BRPI0416692A (pt) | inibidores heterocìclicos de mek e métodos de emprego destes | |
| BRPI0407253A (pt) | Heterociclil-3-sulfonilindazóis como ligandos 5-hidroxitriptamina-6 processo de preparação dos mesmos, seus usos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os referidos compostos | |
| BR112021011325A2 (pt) | Derivados de rapamicina | |
| BR112021020297A2 (pt) | Compostos de hexa-hidro-1h-pirazino[1,2-a]pirazina para o tratamento de doença autoimune | |
| EA201992090A1 (ru) | ДЕЙТЕРИРОВАННЫЕ СОЕДИНЕНИЯ ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА | |
| MX2022000598A (es) | Preparacion de compuestos antibacterianos. | |
| BR112022009487A2 (pt) | Compostos antagonistas do receptor de adenosina | |
| BRPI0513513A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito inibitório de eg5 e um efeito anticáncer em um animal de sangue quente, e para tratar carcinomas em um animal de sangue quente | |
| BR112022007680A2 (pt) | Derivados de n-(heteroaril)quinazolin-2-amina como inibidores de lrrk2, composições farmacêuticas, e usos dos mesmos | |
| BRPI0511874A (pt) | derivados da pirrolopiridina |